Compare BLCO & UEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | UEC |
|---|---|---|
| Founded | 1853 | 2003 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.9B |
| IPO Year | 2022 | 2008 |
| Metric | BLCO | UEC |
|---|---|---|
| Price | $16.25 | $10.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 5 |
| Target Price | $18.45 | ★ $18.95 |
| AVG Volume (30 Days) | 344.9K | ★ 9.5M |
| Earning Date | 04-29-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,101,000,000.00 | $66,837,000.00 |
| Revenue This Year | $8.65 | N/A |
| Revenue Next Year | $5.59 | $220.11 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 6.47 | ★ 29737.95 |
| 52 Week Low | $13.09 | $6.42 |
| 52 Week High | $18.92 | $20.34 |
| Indicator | BLCO | UEC |
|---|---|---|
| Relative Strength Index (RSI) | 51.33 | 42.55 |
| Support Level | $15.36 | $10.12 |
| Resistance Level | $16.54 | $11.31 |
| Average True Range (ATR) | 0.48 | 0.58 |
| MACD | 0.07 | 0.04 |
| Stochastic Oscillator | 52.59 | 39.59 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Uranium Energy Corp is a uranium mining company engaged in the exploration, extraction, and processing of uranium and titanium concentrates across projects in the United States, Canada, and Paraguay. The Company operates through multiple segments, including uranium mining activities in Wyoming, Texas, Saskatchewan, and other regions, along with a corporate segment focused on investments and uranium inventory trading. It is expanding its portfolio of low-cost uranium projects in stable North American locations and operates a Wyoming-based ISR (In-Situ Recovery) Hub and Spoke platform. This platform is supported by two fully operational central processing plants and seven U.S. ISR uranium projects.